Drug Shortage Report for TEVA-ROSUVASTATIN

Last updated on 2020-01-25 History
Report ID 103561
Drug Identification Number 02354624
Brand name TEVA-ROSUVASTATIN
Common or Proper name ROSUVASTATIN 20MG TAB
Company Name TEVA CANADA LIMITED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-15
Estimated end date 2020-02-29
Actual end date 2020-01-24
Shortage status Resolved
Updated date 2020-01-25
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-01-25 English Compare
v4 2020-01-24 French Compare
v3 2020-01-24 English Compare
v2 2020-01-17 French Compare
v1 2020-01-17 English Compare